Clearside Biomedical, Inc.
Hedge Funds Holdings
Last updated:
Clearside Biomedical, Inc.‘s stocks are currently a part of 31 hedge funds’ portfolios, which represents 7.9% of the total amount of its stocks outstanding. This makes up a total of 4.75M shares of Clearside Biomedical, Inc.. Compared to the previous quarter, the number fell by -47.91% or -4.37M shares fewer. As for the holding position changes, 9.68% (3) of current hedge fund investors increased the number of shares held, 32.26% (10) of current holders sold a part of the shares held, and 25.81% (8) closed the holdings completely. 5 hedge funds are new holders of Clearside Biomedical, Inc. stock in Q1 2023, it is 16.13% of total holders.
Hedge funds holding Clearside Biomedical (Q2 2018 – Q1 2023)
| Q2 2018 | 86 |
|---|---|
| Q3 2018 | 87 |
| Q4 2018 | 68 |
| Q1 2019 | 57 |
| Q2 2019 | 46 |
| Q3 2019 | 32 |
| Q4 2019 | 46 |
| Q1 2020 | 41 |
| Q2 2020 | 44 |
| Q3 2020 | 40 |
| Q4 2020 | 40 |
| Q1 2021 | 52 |
| Q2 2021 | 53 |
| Q3 2021 | 66 |
| Q4 2021 | 64 |
| Q1 2022 | 57 |
| Q2 2022 | 50 |
| Q3 2022 | 51 |
| Q4 2022 | 52 |
| Q1 2023 | 31 |
Hedge funds changes in Clearside Biomedical positions (Q2 2018 – Q1 2023)
| Q2 2018 | 24 | 28 | 23 | 17 | -6 |
|---|---|---|---|---|---|
| Q3 2018 | 16 | 34 | 20 | 15 | 2 |
| Q4 2018 | 13 | 18 | 26 | 32 | -21 |
| Q1 2019 | 7 | 11 | 21 | 18 | 0 |
| Q2 2019 | 10 | 6 | 16 | 19 | -5 |
| Q3 2019 | 6 | 3 | 10 | 20 | -7 |
| Q4 2019 | 20 | 7 | 9 | 6 | 4 |
| Q1 2020 | 8 | 13 | 8 | 10 | 2 |
| Q2 2020 | 10 | 12 | 9 | 7 | 6 |
| Q3 2020 | 5 | 11 | 9 | 9 | 6 |
| Q4 2020 | 7 | 10 | 9 | 7 | 7 |
| Q1 2021 | 17 | 18 | 6 | 4 | 7 |
| Q2 2021 | 10 | 13 | 15 | 9 | 6 |
| Q3 2021 | 20 | 23 | 9 | 6 | 8 |
| Q4 2021 | 17 | 23 | 12 | 18 | -6 |
| Q1 2022 | 9 | 14 | 21 | 16 | -3 |
| Q2 2022 | 5 | 7 | 23 | 11 | 4 |
| Q3 2022 | 7 | 6 | 20 | 6 | 12 |
| Q4 2022 | 13 | 9 | 14 | 11 | 5 |
| Q1 2023 | 5 | 3 | 10 | 8 | 5 |
Hedge funds changes in Clearside Biomedical stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 885,000 | 1,570,000 |
|---|---|---|
| Q3 2018 | 455,000 | 701,000 |
| Q4 2018 | 81,000 | 3,000 |
| Q1 2019 | 88,000 | 136,000 |
| Q2 2019 | 67,000 | 96,000 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 254,000 | 1,832,000 |
| Q1 2020 | 123,000 | 1,796,000 |
| Q2 2020 | 14,000 | 1,545,000 |
| Q3 2020 | 56,000 | 0 |
| Q4 2020 | 92,000 | 0 |
| Q1 2021 | 556,000 | 437,000 |
| Q2 2021 | 2,709,000 | 1,389,000 |
| Q3 2021 | 4,571,000 | 3,087,000 |
| Q4 2021 | 2,483,000 | 1,477,000 |
| Q1 2022 | 470,000 | 579,000 |
| Q2 2022 | 305,000 | 372,000 |
| Q3 2022 | 221,000 | 218,000 |
| Q4 2022 | 228,808 | 59,168 |
| Q1 2023 | 31,547,000 | 5,215,000 |